JP2008508188A5 - - Google Patents

Download PDF

Info

Publication number
JP2008508188A5
JP2008508188A5 JP2007504792A JP2007504792A JP2008508188A5 JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5 JP 2007504792 A JP2007504792 A JP 2007504792A JP 2007504792 A JP2007504792 A JP 2007504792A JP 2008508188 A5 JP2008508188 A5 JP 2008508188A5
Authority
JP
Japan
Prior art keywords
thiazol
ethyl
phenyl
amino
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007504792A
Other languages
English (en)
Japanese (ja)
Other versions
JP4978464B2 (ja
JP2008508188A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2005/014136 external-priority patent/WO2006011631A2/en
Publication of JP2008508188A publication Critical patent/JP2008508188A/ja
Publication of JP2008508188A5 publication Critical patent/JP2008508188A5/ja
Application granted granted Critical
Publication of JP4978464B2 publication Critical patent/JP4978464B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007504792A 2004-07-27 2005-07-27 Vap−1阻害剤活性を有するチアゾール誘導体 Expired - Fee Related JP4978464B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004904196 2004-07-27
AU2004904196A AU2004904196A0 (en) 2004-07-27 Thiazole Derivatives Having VAP-1 Inhibitory Activity
PCT/JP2005/014136 WO2006011631A2 (en) 2004-07-27 2005-07-27 Thiazole derivatives having vap-1 inhibitory activity

Publications (3)

Publication Number Publication Date
JP2008508188A JP2008508188A (ja) 2008-03-21
JP2008508188A5 true JP2008508188A5 (enExample) 2008-08-14
JP4978464B2 JP4978464B2 (ja) 2012-07-18

Family

ID=35734947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007504792A Expired - Fee Related JP4978464B2 (ja) 2004-07-27 2005-07-27 Vap−1阻害剤活性を有するチアゾール誘導体

Country Status (10)

Country Link
US (1) US20070254931A1 (enExample)
EP (1) EP1786792B1 (enExample)
JP (1) JP4978464B2 (enExample)
KR (1) KR20070050932A (enExample)
CN (1) CN101031555A (enExample)
AT (1) ATE427941T1 (enExample)
CA (1) CA2575411A1 (enExample)
DE (1) DE602005013793D1 (enExample)
ES (1) ES2324922T3 (enExample)
WO (1) WO2006011631A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103554095A (zh) 2006-02-15 2014-02-05 Abbvie公司 新的乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
CN101384568B (zh) * 2006-02-15 2012-12-12 雅培制药有限公司 乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用
US20100190834A1 (en) * 2007-06-25 2010-07-29 R-Tech Ueno, Ltd. Composition for ophtalmic disease associated with hypoxia or ischemia
KR20100096094A (ko) 2007-10-19 2010-09-01 가부시키가이샤 아루떼꾸 우에노 백내장 처치를 위한 의약 조성물
US20090170770A1 (en) * 2007-11-06 2009-07-02 Ali Hafezi-Moghadam Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap 1) inhibitor
BRPI0906925A2 (pt) * 2008-01-18 2019-09-24 Allergan Inc agentes adrenérgicos do subtipo alfa 2 seletivos e métodos de uso dos mesmos
TWI437986B (zh) 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為vap-1抑制劑之用途
TWI490214B (zh) 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
JP2012506386A (ja) * 2008-10-21 2012-03-15 メタボレックス, インコーポレイテッド アリールgpr120受容体アゴニストおよびその使用
UA112154C2 (uk) 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
EA024102B1 (ru) 2011-03-15 2016-08-31 Астеллас Фарма Инк. Гуанидиновые соединения, полезные для предотвращения и/или лечения диабетической нефропатии или диабетического отека желтого пятна
JP6050238B2 (ja) 2011-10-19 2016-12-21 興和株式会社 新規なスピロインドリン化合物、及びそれを含有する医薬
US20160113893A1 (en) 2013-06-12 2016-04-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
ES2714125T3 (es) 2014-04-15 2019-05-27 Pecsi Tudomanyegyetem Inhibidores de la amino oxidasa sensible a la semicarbazida para uso como analgésicos en una neuropatía traumática y una inflamación neurogénica
WO2015189534A1 (en) 2014-06-12 2015-12-17 Proximagen Limited Vap-1 inhibitors for treating muscular dystrophy
CN104478828B (zh) * 2014-12-10 2016-07-06 漳州片仔癀药业股份有限公司 2-氨基-7-取代苯并噻唑类化合物及其制备方法与用途
JO3546B1 (ar) 2015-01-09 2020-07-05 Kyowa Kirin Co Ltd طريقة لإنتاج مشتق ثيازول
JP2018076236A (ja) 2015-06-05 2018-05-17 株式会社アールテック・ウエノ がんを処置するための医薬組成物
MX383577B (es) * 2015-08-06 2025-03-14 Ube Industries Derivados sustituidos de guanidina.
CA3007768A1 (en) 2015-12-07 2017-06-15 Benevolentai Cambridge Limited Vap-1 inhibitors for treating pain
EP3455216B1 (en) * 2016-05-12 2020-11-04 Boehringer Ingelheim International GmbH Pyridinyl derivatives, pharmaceutical compositions and uses thereof as aoc3 inhibitors
MX2019007786A (es) * 2016-12-28 2019-08-16 Ube Industries Compuestos sustituidos de guanidina.
US10213306B2 (en) 2017-03-31 2019-02-26 Neochord, Inc. Minimally invasive heart valve repair in a beating heart

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511574A (en) * 1981-01-08 1985-04-16 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-Phenyl-2-thiazolyl)carbamate derivatives
US4699928A (en) * 1984-07-13 1987-10-13 Merrell Dow Pharmaceuticals Inc. Fluoroallylamine derivatives
IT1181871B (it) * 1985-04-01 1987-09-30 Consiglio Nazionale Ricerche Inibitori selettivi delle benzilamminossidasi rispetto ad altre amminossidasi
US4650907A (en) * 1985-12-05 1987-03-17 Merrell Dow Pharmaceuticals Inc. Nonaromatic fluoroallylamine MAO inhibitors
US4916151A (en) * 1985-12-05 1990-04-10 Merrell Dow Pharmaceuticals Inc. Method of treating parkinson's syndrome
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4943593A (en) * 1988-02-25 1990-07-24 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5021456A (en) * 1988-02-25 1991-06-04 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059814A (en) * 1988-11-30 1991-10-22 The California Institute Of Technology Winner-take-all circuits for neural computing systems
JPH0848664A (ja) * 1994-08-05 1996-02-20 Hisamitsu Pharmaceut Co Inc 新規なグアニジノ安息香酸エステル誘導体
GB9506188D0 (en) * 1995-03-27 1995-05-17 Fujisawa Pharmaceutical Co Amidine derivatives
IL153767A0 (en) * 2000-07-05 2003-07-06 Biotie Therapies Corp Inhibitors of copper-containing amine oxidases
AU2002214505A1 (en) * 2000-11-09 2002-05-21 Biovitrum Ab New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives
CA2514573A1 (en) * 2003-01-27 2004-08-12 Astellas Pharma Inc. Thiazole derivatives and their use as vap-1 inhibitors
KR20120045062A (ko) * 2003-03-31 2012-05-08 가부시키가이샤 아루떼꾸 우에노 혈관 과투과 질환의 치료방법
US20070208068A1 (en) * 2004-03-18 2007-09-06 R-Tech Ueno, Ltd. & Astellas Pharma Inc. Aqueous Composition Comprising Thiazole Derivative

Similar Documents

Publication Publication Date Title
JP4978464B2 (ja) Vap−1阻害剤活性を有するチアゾール誘導体
JP4650412B2 (ja) チアゾール誘導体およびvap−1阻害剤としてのその使用
AU2009209885B2 (en) Thiazole derivative and use thereof as VAP-1 inhibitor
JP4758337B2 (ja) 血管透過性亢進疾患を治療する方法
US20080015202A1 (en) Thiazole Derivatives Having Vap-1 Inhibitory Activity
JP2008512346A5 (enExample)
CN1209352C (zh) 肼衍生物
US20110269953A1 (en) Nitrogen and Sulfur-Containing Heterocycle Derivatives